Preannouncment: Crowdinvesting campaign on aescuvest

In the fight against coronaviruses the team of the ImmunoLogik identified a promising lead candidate for the treatment of people infected with SARS-CoV-2.

For the funding of the next steps in the drug development of the lead candidate IML-206 the ImmunoLogik starts a new crowdinvesting campaign on and  in the context of the #CrowdBeatsCorona alliance.

You find more information about the preannouncement in aescuvest’s blog.

In order not to miss the start of the crowdinvesting campaign, subscribe to aescuvest’s newsletter.